[ad_1]
Researchers from the University of the Basque Country (Northern Spain) found a molecular key to delay the progression of multiple sclerosis, a finding published in EMBO Molecular Medicine journal scientist ] reported today the study center
Multiple sclerosis is an autoimmune disease that attacks and destroys a structure called "myelin sheath" whose integrity is indispensable in the proper functioning of the brain and spinal cord.
You will discover the cell that could regenerate the entire body
The current treatment of multiple sclerosis is based on the modulation of the body's activity. immune system, and prevent their cells from accessing the central nervous system, and damage it. These therapies are effective in the early stages of the disease, but do not prevent their progression and progressive functional deterioration.
In the work that has just been published, it was possible to identify a receptor named P2X4 in microglial cells that increase their anti-inflammatory potential, in order to reduce damage in multiple sclerosis and, most importantly, improve the body's own repair responses.
According to the physician Maria Domercq, of the Department of Neuroscience of the UPV / EHU, who works in the research center Achucarro de Leioa "It is a discovery that opens a new pathway of pharmacological development for the treatment of the progressive phase of multiple sclerosis, and with that we want to open a new door to improving the quality of life." people who suffer from it. "
In this ambitious study, coordinated by research Basque Country also collaborated professionals of the University of Hamburg in Germany and of the Institute of Functional Genomics in Montpellier, France.
EFE
[ad_2]
Source link
